A Stereoselective Approach to Functionalized Cyclohexenones

Enantioselective Total Synthesis of (+)-Pedrolide

The first total synthesis of (+)-pedrolide, a tigliane-derived diterpenoid featuring an unprecedented 5-5-6-6-3 carbon skeleton, is reported. Key to the approach is the construction of the bicyclo[2.2.1]heptane core via an intramolecular cyclopentadiene-Diels-Alder cycloaddition. To this end, a norbornadiene serves as an effective surrogate for cyclopentadiene, which is unmasked under mild conditions involving a complex Diels-Alder reaction cascade. In addition, the synthesis provides a novel approach to a densely functionalized carane in an efficient and enantioselective manner.

Reductive Aromatization of Quinols with B2 pin2 as Deoxidizing Agent

We have demonstrated B₂ pin₂ as superior deoxidizing agent for the reductive deoxygenation of quinol derivatives under basic conditions. A wide range of highly functionalized phenols were obtained in good yields including a complex drug molecule, which revealed the high functional group tolerance of this protocol.

Rh-Catalyzed diastereoselective desymmetrization of enone tethered-cyclohexadienones via tandem arylative cyclization

The rhodium-catalyzed arylative cyclization of enone tethered-cyclohexadienones has been developed with high efficiency, thus providing cis-fused bicyclic enones in good yields and with excellent diastereoselectivities.

Diastereoselective Synthesis of Morphan Derivatives by Michael and Hetero-Michael Addition of 1,1-Enediamines to Quinone Monoketals

A general and concise method was developed for the synthesis of highly functionalized morphans 3-4 by the Michael and hetero-Michael addition reaction of different types of quinone monoketals 1 and 1,1-enediamines 2 in ethanol or 1,4-dioxane at reflux. This method is suitable for the efficient parallel syntheses of N-containing heterocycles. A library of highly functional morphan derivatives was easily constructed using the Michael/hetero-Michael reaction.

Antroquinonol A: Scalable Synthesis and Preclinical Biology of a Phase 2 Drug Candidate

The fungal-derived Taiwanese natural product antroquinonol A has attracted both academic and commercial interest due to its reported exciting biological properties. This reduced quinone is currently in phase II trials (USA and Taiwan) for the treatment of non-small-cell lung carcinoma (NSCLC) and was recently granted orphan drug status by the FDA for the treatment of pancreatic cancer and acute myeloid leukemia. Pending successful completion of human clinical trials, antroquinonol is expected to be commercialized under the trade name Hocena. A synthesis-enabled biological re-examination of this promising natural product, however, reveals minimal in vitro and in vivo antitumor activity in preclinical models.

Asymmetric synthesis of Ampelomin A and ent-Epiampelomin A

We synthesized the naturally occurring carbasugar ampelomin A and its epimer from a common starting material. The enantiomerically pure starting material was obtained by base-catalyzed asymmetric Diels-Alder reaction of 3-hydroxy-2-pyrone and chiral acrylate. The total yield of ampelomin A was 14% in seven synthetic steps. The key step of the synthesis of ampelomin A was inversion of the stereochemistry at the C-6 position, which was achieved by stereoselective catalytic hydrogenation of the corresponding methylidene group. Further synthesis of the epimer was straightforward, because all stereogenic centers had already been introduced on the starting material; the total yield was 44% in four synthetic steps. Both the final products were obtained in pure form without contamination with undesired isomers. The reported (1)H NMR chemical shift of the C-7 methyl protons and the H-5axial coupling pattern of natural ampelomin A were inconsistent with those of our synthetic product. After careful comparison of the spectra and examination of the stable conformation obtained through MM2 calculations, we present revised NMR data for ampelomin A.

Asymmetric transformations of achiral 2,5-cyclohexadienones

Cyclohexadienones are versatile platforms for performing asymmetric synthesis as evidenced by the numerous natural product syntheses that exploit their diverse reactivity profile. However, there are few general methods available for the direct asymmetric synthesis of chiral cyclohexadienones. To circumvent this problem, several researchers have developed catalytic asymmetric methods that employ readily available achiral 2,5-cyclohexadienones as substrates. Many of these reactions are desymmetrizations in which one of the enantiotopic alkenes of an achiral dienone is transformed. Others involve selective reaction at one alkene of an unsymmetrically substituted, achiral dienone. This review will cover advances in this area over the last 20 years and the application of these strategies in complex molecule synthesis.